Disseminated fungal infection following falciparum malaria

Journal of Infection

Volumn 40, Issue 2, 2000, Pages 202-204

  Wilson, A P R ^a   Wright, S ^a   Bellingan, G ^a  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; VORICONAZOLE;

ABSIDIA; ADULT; ARTICLE; ASPERGILLUS FLAVUS; CASE REPORT; FATALITY; HUMAN; MALARIA FALCIPARUM; MALE; MYCOSIS;

EID: 0034069118     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2000.0637     Document Type: Article

References (17)

1. Record NB, Ginder DR. Pulmonary phycomycosis without obvious predisposing factors. JAMA. 235:1976;1256-1257.
2. Ericsson M, Anniko M, Gustafsson H, Hjalt C-A, Stenling R, Tarnvik A. A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis. 16:1993;585-586.
3. Viscoli C, Dodi F, Pellicci E. Staphylococcus aureus bacteraemia, Absidia corymbifera infection and probable pulmonary aspergillosis in a recipient of orthotopic liver transplantation for end stage liver disease secondary to hepatitis C. J Infect. 34:1997;281-285.
4. Jantunen E, Kolho E, Ruutu P. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation. Bone Marrow Transplant. 18:1996;229-230.
5. Leong KW, Crowley B, White B. Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant. 19:1997;513-515.
6. Mackenzie DWR, Soothill JF, Millar JHD. Meningitis caused by Absidia corymbifera. J Infect. 17:1988;241-248.
7. 1in flour production. Eur J Epidemiol. 10:1994;555-558.
8. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis. 19:1994;402-408.
9. Murphy M, Bernard EM, Ishimaru T, Armstrong D. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Ag Chemother. 41:1997;696-698.
10. Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol. 97:1997;663-665.
11. Carrano CJ, Bohnke R, Matzanke BF. Fungal ferritins: the ferritin from mycelia of Absidia spinosa is a bacterioferritin. FEBS Lett. 390:1996;261-264.
12. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 31:1982;1109-1114.
13. Boelaert JR, de Locht M, Van Cutsem J. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest. 91:1993;1979-1986.
14. Anstey NM, Weinberg JB, Hassanali MY. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med. 184:1996;557-567.
15. Owens AW, Hacklette MS, Baker RD. An antifungal factor in human serum. I. Studies of Rhizopus rhizopodiformis. Sabouraudia. 4:1965;179.
16. Soesan M, Kager PA, Leverstein-van Hall MA, van Lieshout JJ. Coincidental severe Plasmodium falciparum infection and disseminated candidiasis. Trans Roy Soc Trop Med Hyg. 87:1993;288-289.
17. Ashiru JO, Akang EE. Cryptococcal meningitis with malaria. A case report. Mycopathologia. 127:1994;15-17.